Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors-Reference-Cited by-同舟云学术

Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors

Published:2018-01 Issue: Volume:89 Page:56-63
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ameratunga Malaka^ORCID,Chénard-Poirier Maxime,Moreno Candilejo Irene,Pedregal Manuel,Lui Andrew,Dolling David,Aversa Caterina,Ingles Garces Alvaro^ORCID,Ang Joo Ern,Banerji Udai^ORCID,Kaye Stan^ORCID,Gan Hui,Doger Bernard,Moreno Victor,de Bono Johann,Lopez Juanita

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial;Seiwert;Lancet Oncol,2016

3. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial;Rosenberg;Lancet,2016

4. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N. Engl J Med,2015

5. Pembrolizumab for the treatment of non–small-cell lung cancer;Garon;N. Engl J Med,2015

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer;Cell & Bioscience;2024-09-12

2. Predictive value of early dynamic changes of NLR and PLR for the efficacy of immune checkpoint inhibitor in head and neck squamous cell carcinoma;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-08

3. Lymphocyte activation markers predict the therapeutic response to immune checkpoint inhibitors: A case–control study;Cancer Medicine;2024-06

4. Predictive value of PD-L1 and TMB for short-term efficacy prognosis in non-small cell lung cancer and construction of prediction models;Frontiers in Oncology;2024-05-02

5. Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience;Pediatric Blood & Cancer;2024-04-28